A detailed history of Logos Global Management LP transactions in Dyne Therapeutics, Inc. stock. As of the latest transaction made, Logos Global Management LP holds 265,000 shares of DYN stock, worth $7.45 Million. This represents 0.88% of its overall portfolio holdings.

Number of Shares
265,000
Previous 265,000 -0.0%
Holding current value
$7.45 Million
Previous $9.35 Million -0.0%
% of portfolio
0.88%
Previous 0.88%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$23.65 - $35.63 $34.6 Million - $52.2 Million
-1,465,000 Reduced 84.68%
265,000 $9.35 Million
Q1 2024

May 15, 2024

SELL
$13.06 - $29.18 $1.96 Million - $4.38 Million
-150,000 Reduced 7.98%
1,730,000 $49.1 Million
Q4 2023

Feb 14, 2024

SELL
$6.62 - $13.64 $1.99 Million - $4.09 Million
-300,000 Reduced 13.76%
1,880,000 $25 Million
Q3 2023

Nov 14, 2023

BUY
$8.6 - $12.18 $3.44 Million - $4.87 Million
400,000 Added 22.47%
2,180,000 $19.5 Million
Q2 2023

Aug 14, 2023

BUY
$8.53 - $14.28 $682,400 - $1.14 Million
80,000 Added 4.71%
1,780,000 $20 Million
Q1 2023

May 15, 2023

SELL
$10.88 - $15.0 $4.9 Million - $6.75 Million
-450,000 Reduced 20.93%
1,700,000 $19.6 Million
Q4 2022

Feb 14, 2023

SELL
$9.37 - $13.8 $1.29 Million - $1.9 Million
-137,321 Reduced 6.0%
2,150,000 $24.9 Million
Q3 2022

Nov 14, 2022

SELL
$7.2 - $15.17 $4.41 Million - $9.29 Million
-612,679 Reduced 21.13%
2,287,321 $29 Million
Q2 2022

Aug 15, 2022

BUY
$4.36 - $10.5 $722,050 - $1.74 Million
165,608 Added 6.06%
2,900,000 $19.9 Million
Q1 2022

May 16, 2022

SELL
$6.52 - $12.27 $3.26 Million - $6.14 Million
-500,000 Reduced 15.46%
2,734,392 $26.4 Million
Q4 2021

Feb 14, 2022

SELL
$11.89 - $16.07 $4.58 Million - $6.19 Million
-385,000 Reduced 10.64%
3,234,392 $38.5 Million
Q3 2021

Nov 15, 2021

BUY
$15.6 - $21.46 $24.4 Million - $33.6 Million
1,565,000 Added 76.18%
3,619,392 $58.8 Million
Q2 2021

Aug 16, 2021

SELL
$15.94 - $22.33 $18.3 Million - $25.7 Million
-1,150,000 Reduced 35.89%
2,054,392 $43.2 Million
Q1 2021

May 17, 2021

BUY
$14.0 - $29.3 $22.4 Million - $46.9 Million
1,600,000 Added 99.73%
3,204,392 $49.8 Million
Q3 2020

Nov 17, 2020

BUY
$20.0 - $23.9 $16.1 Million - $19.2 Million
804,392 Added 100.55%
1,604,392 $32.4 Million
Q3 2020

Nov 16, 2020

BUY
$20.0 - $23.9 $16 Million - $19.1 Million
800,000 New
800,000 $16.2 Million

Others Institutions Holding DYN

About Dyne Therapeutics, Inc.


  • Ticker DYN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 51,765,400
  • Market Cap $1.46B
  • Description
  • Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...
More about DYN
Track This Portfolio

Track Logos Global Management LP Portfolio

Follow Logos Global Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Logos Global Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Logos Global Management LP with notifications on news.